Logomix, Inc.

Logomix is a synthetic biology company, reshaping the landscape of human genome engineering. Its Geno-Writing™ platform enables precise engineering of Mb-scale genomic sequences within human cells, and thus facilitates the development of super-functionalized cells for the fields of cell therapy, regenerative medicine and any future cell-based therapies.